Reinvent Biologics Appoints David Drez, MD as a Chief Medical Officer
September 25 2018 - 11:08AM
Business Wire
Fort Worth-based Reinvent Biologics announced the appointment of
David Drez Jr., MD as Chief Medical Officer.
As Chief Medical Officer, Drez will provide strategic leadership
on all of Reinvent Biologics medical education and research
activities. He will research and track current clinical trends and
provide training and support to medical professionals to optimize
patient outcomes with Reinvent Biologics products. He will also
serve as a resource on Reinvent’s sales efforts.
With a career spanning more than 42 years, Dr. Drez is one of
the nation’s leading experts in orthopedics and sports medicine.
The co-author of the highly acclaimed Orthopedic Sports Medicine
and co-editor of Operative Techniques in Sports Medicine, Drez was
the 2017 recipient of the Jack Weakley Award of Distinction from
the National Athletic Trainer’s Association for a lifetime of
outstanding contributions directly impacting health care in the
area of athletics, athletic training, or sports medicine. Drez
served as a team physician at McNeese State University for 37 years
and was inducted into the University’s Hall of Fame. The
rehabilitation area of the University’s Sports Medicine Center was
named in his honor.
“Dr. Drez has spent his career sharing his knowledge and
experience with future generations of physicians. He is a man of
great character with a passion to teach,” said Bryant Gaines, CEO
of Reinvent Biologics. “Throughout his distinguished career, he has
elevated the standard of care provided to the patient. With such a
great amount of research coming out on regenerative medicine, Dr.
Drez will put us in a position to digest the data and effectively
disseminate the knowledge to our distributors and customers.”
Drez earned his undergraduate and medical degrees from Tulane
University. He completed a residency in general surgery and in
orthopedic surgery at Charity Hospital in New Orleans – Tulane
Service. He has published a large body of peer-reviewed research
that has focused primarily on athletic injuries and their
prevention and treatment options, particularly injuries of the knee
and shoulder. He served as a Clinical Professor of Orthopaedics at
Louisiana State University School of Medicine in New Orleans and a
Clinical Assistant Professor of Orthopaedic Surgery at Baylor
College of Medicine in Houston.
“Working with Reinvent Biologics will give me the opportunity to
connect orthopedic medicine and regenerative medicine,” said Drez.
“It’s the right time to increase awareness of the true benefits of
regenerative medicine.”
About Reinvent Biologics
Fort Worth-based Reinvent Biologics, LLC discovers, invents,
develops, manufactures, and commercializes new and innovative
products in the field of regenerative medicine. Our goal is to
address serious medical conditions, across multiple and diverse
therapeutic areas. We are focused on providing physicians cost
effective treatment options while improving the standard of care
through a complete offering of science based biologic solutions.
Learn more at www.reinventbiologics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180925005863/en/
Reinvent BiologicsJoe Moore, 817-736-1557